Treatment of acrodermatitis enteropathica by intravenous amino acid hydrolysate.
D000169:Acrodermatitis / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D000596:Amino Acids / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use; D002364:Caseins / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007275:Injections, Intravenous; D011492:Protein Hydrolysates / Q000008:administration & dosage* / Q000627:therapeutic use; D012867:Skin / Q000473:pathology
D000596:Amino Acids; D002364:Caseins; D011492:Protein Hydrolysates